Skip to main content
Feng-Ming Kong, MD, Radiation Oncology, Cleveland, OH, WellStar MCG Health, affiliated with Medical College of Georgia

Feng-MingPhoenixKongMD

Radiation Oncology Cleveland, OH

Physician

Dr. Kong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kong's full profile

Already have an account?

Summary

  • Yes I am an American board certified radiation oncologist and Professor with over 200 publications and NIH R01 grant. I had postdoctoral training from Duke University Medical Center, and finished my radiation oncology residency program at Washington University at St. Louis.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 1999 - 2003
  • University of Vermont Medical Center
    University of Vermont Medical CenterInternship, Transitional Year, 1998 - 1999
  • Shanghai Medical University
    Shanghai Medical UniversityClass of 1985

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2018 - 2024
  • GA State Medical License
    GA State Medical License 2013 - 2019
  • IN State Medical License
    IN State Medical License 2016 - 2019
  • MI State Medical License
    MI State Medical License 2003 - 2016
  • VT State Medical License
    VT State Medical License 1998 - 1999

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer  
    Feng-Ming Kong, Nirav Kapadia, The Annals of Thoracic Surgery

Lectures

  • Long-term survival comparison of stereotactic radiotherapy versus surgery for elderly patients with clinical stage T1-T2 non-small cell lung cancer. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
  • The effect of thoracic radiation on overall survival and their association with systemic immune therapy in stage IV NSCLC: Findings from the National Cancer Database. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Hospital Affiliations